Table 2.
Lipid profile of patients with COVID-19.
| Variable | Global (n = 43) |
Outpatient management (n = 14) |
Hospitalized (n = 29) |
p |
|---|---|---|---|---|
| Median (range) | ||||
| Triglyceride (mg/dL) | 147 (72–513) | 138 (83–231) | 164 (72–513) | 0.159 |
| Total cholesterol (mg/dL) | 142.5 (70–283) | 147 (70–192) | 130 (71–283) | 0.554 |
| HDL c (mg/dL) | 29.5 (9.6–63.5) | 40.5 (20.1–51.6) | 25.6 (9.6–63.5) | 0.009 |
| LDL c (mg/dL) | 76.4 (25–166) | 68 (28.1–120) | 78 (25–166) | 0.822 |
| Tg/HDL c | 5 (1.3–26.4) | 3.3 (2.7–7.2) | 6.4 (1.3–26.4) | 0.005 |
Table 2: The value of p was derived from ∗U Mann Whitney test. Statistical significance p values are shown in bold (p < 0.05).
Abbreviations: HDL c, High-density lipoprotein cholesterol; LDL c, Low-density lipoprotein cholesterol; Tg/HDL c, Triglyceride/High-density lipoprotein cholesterol ratio.